Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thoracic Neoplasms × Ultrasonography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 7 Thyroid Nodule 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcopenia 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Neoplasms 3 Mouth Neoplasms 3 Liver Neoplasms 3 Liver Cirrhosis 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Thyroid Neoplasms 2 Ovarian Neoplasms 2 Ovarian Cysts 2 Lung Neoplasms 2 Hypersensitivity 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Thrombosis 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1

Interventions

Carboplatin 6 atezolizumab 3 Paclitaxel 3 apatinib 2 Bevacizumab 2 toripalimab 1 sintilimab 1 pegylated granulocyte colony-stimulating factor 1 durvalumab 1 cemiplimab 1 camrelizumab 1 Ultrasonography 1 Tyrosine Kinase Inhibitors 1 Telescopes 1 Sunitinib 1 Sodium Chloride 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Pemetrexed 1 Nivolumab 1 Magnetic Resonance Imaging 1 Kyphoplasty 1 Injections, Epidural 1 Injections 1 Indocyanine Green 1 Etoposide 1 Erlotinib Hydrochloride 1 Electrocardiography 1 Echocardiography 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡